William Blair Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $98.8M | Sell |
|
|||||
|
2023
Q4 | $87.6M | Sell |
|
|||||
|
2023
Q3 | $75.7M | Sell |
|
|||||
|
2023
Q2 | $82.9M | Sell |
|
|||||
|
2023
Q1 | $140M | Sell |
|
|||||
|
2022
Q4 | $155M | Sell |
|
|||||
|
2022
Q3 | $143M | Sell |
|
|||||
|
2022
Q2 | $215M | Sell |
|
|||||
|
2022
Q1 | $294M | Sell |
|
|||||
|
2021
Q4 | $406M | Buy |
|
|||||
|
2021
Q3 | $389M | Sell |
|
|||||
|
2021
Q2 | $362M | Sell |
|
|||||
|
2021
Q1 | $288M | Buy |
|
|||||
|
2020
Q4 | $32.7M | Sell |
|
|||||
|
2020
Q3 | $37.5M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $188M | Sell |
|
|||||
|
2018
Q1 | $182M | Buy |
|
|||||
|
2017
Q4 | $154M | Buy |
|
|||||
|
2017
Q3 | $4.87M | Buy |
|